Tipsheet
What matters at India’s listed companies
Brief /Earnings / Textiles

Faze Three profit drops 30% despite 31% revenue growth

Derivative losses and rising expenses erased the gains from a strong sales year.

1 earlier story on Faze Three Ltd.
Mkt cap₹1,173 cr
P/E37.37×
ROE9.68%
Debt / eq.0.43
-29.6% Year-on-year decline in standalone net profit to ₹28.05 cr.

What's new with Faze Three Ltd.

  • Standalone revenue grew 30.5% to ₹860.11 cr for FY26.
  • Higher expenses and derivative mark-to-market losses hit the bottom line.
  • Consolidated FY26 revenue reached ₹923.07 cr with ₹33.57 cr in profit.

Why this matters for Faze Three Ltd.

The gap between sales growth and profit contraction exposes a painful cost structure. Derivative losses are the primary culprit behind the slide. This shift suggests that aggressive growth came with heavy margin exposure.

What we're watching

  • Whether derivative losses persist in the coming quarters.
  • The trajectory of operating costs relative to revenue.
  • Management's plan for margin stabilization.

The full read

Faze Three ended the year with a sharp divergence between its top line and its bottom line. Standalone revenue grew 30.5% to reach ₹860.11 crore. But profit fell 29.6% to ₹28.05 crore. Higher expenditure, specifically mark-to-market losses on derivatives, created this disconnect.

Consolidated revenue stood at ₹923.07 crore, yielding ₹33.57 crore in profit. The auditor provided an unmodified report on these numbers.

This is not a story of slowing sales. It is a story of margin erosion caused by financial hedging. The open question remains: how much of this pressure is temporary hedging volatility, and how much is a permanent change to the company's cost base? Until the company details its hedging strategy, top-line growth is a misleading indicator of financial performance. The next test is margin recovery.

Mentioned: Faze Three Ltd
Primary source BSE · NSE · Tijori

Our reading of the company's own disclosure. Always confirm against the original source.